Developer docs
API playgroundTry for free, no card

Search company profiles

International Neuromodulation Society

Full company profile

uuid000iluc

Namestring
International Neuromodulation Society
Legal namestring
International Neuromodulation Society
Company typeenum
Private
Founded yearint
1989
Descriptiontext

The International Neuromodulation Society (INS) is a 501(c)(3) nonprofit professional society founded in 1989 and headquartered in San Francisco, California. It is the oldest and largest multidisciplinary body dedicated to neuromodulation — the alteration of nerve activity through targeted delivery of electrical stimulation or chemical agents to specific neurological sites. The INS serves clinicians, scientists, and bioengineers across neurology, neurosurgery, neurophysiology, pain management, and related disciplines, with 3,000+ members in approximately 60 countries organized through 20+ affiliated regional chapters spanning North America, South America, Europe, Asia, and Oceania. Secondary audiences include patients and caregivers, payers and policy makers, and medical journalists seeking credible information about neuromodulation therapies.

The society's core offerings center on a peer-reviewed scientific journal, recurring congresses, and digital education channels. Neuromodulation: Technology at the Neural Interface is the only MEDLINE-indexed journal dedicated exclusively to the field and has been published since 1998, currently distributed through Wiley. The annual World Congress (17th edition scheduled for Lisbon, May 9-14, 2026) and an interim meeting form the in-person scientific backbone, complemented by webinars, a Virtual Journal Club, hands-on workshops, and The Neuromodulation Podcast. Patient-facing services include condition-specific fact sheets, a searchable clinical trials database, and a Find a Clinic directory. The society is led by an Executive Director (Tia Sofatzis), a Board of Directors, and an elected President (currently Marc Russo), with a lean operating team of 1-10 staff.

The business model is a multi-stream nonprofit funding structure rather than a commercial sales motion. Revenue is generated through member dues, conference and interim meeting registration/exhibition proceeds, royalties from the Wiley-published journal, and unrestricted educational grants from neuromodulation device manufacturers including Abbott, Boston Scientific, Mainstay Medical, Medtronic, Nalu Medical, Nevro Corp., and Saluda Medical. Distribution occurs primarily through neuromodulation.com, regional chapter websites, Wiley Online Library, social media channels, and in-person congresses. The society's go-to-market motion is community-led: growth is driven by member recruitment, scientific reputation, chapter development, and the credibility of its peer-reviewed publication rather than direct sales or paid marketing.

Short descriptiontext

The International Neuromodulation Society is a 501(c)(3) nonprofit founded in 1989 that serves 3,000+ clinicians, scientists, and engineers across 60 countries through a peer-reviewed journal, global congresses, and 20+ regional chapters devoted to advancing neuromodulation science and education.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
neuromodulation education, medical professional society, peer-reviewed journal publishing, medical congress services, neurology research community
NAICS code3 codes
  • Educational Support Services611710
  • Educational Support Services61171
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Educational Services8200
  • Services-Commercial Physical & Biological Research8731
Product category
Professional Medical Society and Neuromodulation Education
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Member Dues
TypeSubscription Recurring
Description

The society collects membership dues from clinicians, scientists, and engineers who join as members.

neuromodulation.com
2Conference Proceeds
TypeSubscription Recurring
Description

Revenue generated from the INS World Congress and interim meetings, including registration fees and exhibition revenue.

neuromodulation.com
3Journal Royalties
TypeSubscription Recurring
Description

Royalties from the peer-reviewed journal Neuromodulation: Technology at the Neural Interface published by Wiley.

neuromodulation.com
4Unrestricted Grants from Industry
TypeSubscription Recurring
Description

The website is supported by unrestricted grants from Abbott, Boston Scientific Corporation, Mainstay Medical, Medtronic Inc., Nalu Medical, Nevro Corp., and Saluda Medical. These are charitable contributions that support website operations.

neuromodulation.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 record
1Neuromodulation: Technology at the Neural Interface
Description

The official peer-reviewed journal of the International Neuromodulation Society, publishing scientific works and reviews on neuromodulation.

neuromodulation.com
Core offering1 text field

The International Neuromodulation Society is a nonprofit professional medical society that advances the science, education, and practice of neuromodulation through a peer-reviewed journal, international congresses, webinars, podcasts, and a global network of regional chapters for clinicians, scientists, and engineers. It also delivers patient-facing educational resources including fact sheets, a clinic finder, and a clinical trials directory.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

The International Neuromodulation Society is a nonprofit professional medical society, not a technology product company. Its offerings consist of membership services and educational resources for healthcare professionals and patients. The core portfolio includes the peer-reviewed journal 'Neuromodulation: Technology at the Neural Interface' (indexed in MEDLINE since 1998), the World Congress (17th scheduled for May 2026 in Lisbon) and Interim Meetings, webinars, workshops, the Neuromodulation Podcast, and INS Regional Chapters spanning over 20 countries. Patient-facing services include fact sheets, clinical trials listings, and a clinic finder directory. The society operates member-only resources with mentorship programs and expert panels. The society does not offer commercial technology products or AI-powered solutions.

Product and service12 records
1Neuromodulation: Technology at the Neural Interface (Journal)
CategoryPeer-reviewed journal
Description

The official MEDLINE-indexed peer-reviewed journal of the INS, publishing scientific works and reviews on neuromodulation research; available to members online and via Wiley for non-members.

2INS World Congress
CategoryScientific congress
Description

Flagship biennial international scientific meeting bringing together clinicians, scientists, and engineers for scientific presentations, workshops, and networking in neuromodulation.

3INS Interim Meeting
CategoryScientific meeting
Description

Intermediate scientific meeting held between World Congresses, providing additional education and collaboration opportunities for neuromodulation professionals.

4INS Webinars
CategoryContinuing education
Description

Online educational webinars providing continuing education and the latest research updates for INS members and healthcare professionals.

5Virtual Journal Club
CategoryContinuing education
Description

Online forum for discussion and analysis of recent peer-reviewed journal articles in neuromodulation.

6INS Workshops
CategoryHands-on training
Description

Hands-on training workshops for medical professionals covering neuromodulation techniques and procedures.

7The Neuromodulation Podcast
CategoryEducational media
Description

Podcast series featuring discussions on emerging neuromodulation techniques, insights, ethical and clinical applications, and multidisciplinary collaboration.

8INS Regional Chapters
CategoryMembership chapters
Description

Network of 20+ affiliated national chapters spanning Argentina, Australia & New Zealand, Benelux, Brazil, Canada, China, Colombia, France, Germany, Italy, Japan, Korea, Nordic countries, Poland, Russia, South East Europe, Spain, Switzerland, Turkey, UK and Ireland.

9INS Membership Services
CategoryMembership services
Description

Member-only resources including journal access, mentorship programs, expert panels, educational materials, and industry news.

10Find a Clinic Directory
CategoryPatient resources
Description

Directory service helping patients locate clinics offering neuromodulation treatments.

11INS Fact Sheets
CategoryPatient education
Description

Patient-focused educational fact sheets on neuromodulation therapies including deep brain stimulation, spinal cord stimulation, vagus nerve stimulation, epilepsy, and Parkinson's disease.

12Clinical Trials Listings
CategoryClinical research directory
Description

Searchable database of clinical trials involving neuromodulation approaches across chronic pain, movement disorders, epilepsy, psychiatric disorders, brain injury, stroke, cardiovascular, gastrointestinal, and other conditions.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

The INS journal Neuromodulation: Technology at the Neural Interface is published by Wiley. The journal is indexed in Index Medicus, MEDLINE and Pubmed from its first issue in 1998 and has a growing Impact Factor.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeRegional player
Description

Pan-European neurology professional society comparable to AAN in scope and structure, with neuromodulation as a covered subspecialty. Operates regional congresses and a peer-reviewed journal (European Journal of Neurology), serving an overlapping European clinician audience that INS reaches through its European regional chapters.

TypeBroad incumbent
Description

Major US neurosurgical professional society with significant neuromodulation content (DBS, SCS, etc.) and a dedicated section on pain and neuromodulation. Comparable in operating model (membership, journal Neurosurgery, annual meeting) but much broader specialty focus.

TypeDirect peer
Description

US-based academic neurology professional society with peer-reviewed journal (Annals of Neurology) and annual meeting. Comparable in mission and membership model to INS, with significant overlap on the academic neurology researchers who participate in neuromodulation clinical trials.

TypeBroad incumbent
Description

Largest US-based neurology professional society, covering neuromodulation as part of a much broader specialty. Comparable society/membership/journal/congress model but operates at vastly larger scale; many INS members also belong to AAN, making it both a competitor and a partner ecosystem.

TypeDirect peer
Description

Global multidisciplinary professional society focused on pain research and treatment, with spinal cord stimulation and other neuromodulation modalities as a major interest area. Operates a peer-reviewed journal, congresses, and chapters — closely comparable to INS in structure, membership model, and clinical scope.

TypeBroad incumbent
Description

International umbrella society for national neurosurgical organizations worldwide. Overlaps with INS on the neurosurgical neuromodulation community, congress programming, and journal publication, but covers all of neurosurgery rather than specializing in neuromodulation.

TypeDirect peer
Description

Direct peer and INS's North American chapter-affiliated society, also focused on neuromodulation education, research dissemination, and physician membership. Operates its own journal, annual meeting, and continuing education for neuromodulation clinicians — directly overlapping INS's core mission and audience.

TypeDirect peer
Description

International scientific society for clinicians and researchers in movement disorders, including deep brain stimulation — a major neuromodulation application INS also covers. Comparable membership size, journal (Movement Disorders), and congress-driven business model, serving an overlapping physician audience.

TypeDirect peer
Description

International professional society for epilepsy clinicians and researchers, with vagus nerve stimulation and responsive neurostimulation as core neuromodulation topics within its scope. Operates with the same society/journal/congress model and serves an overlapping neuroscience community.

TypeBroad incumbent
Description

Massive US-based neuroscience professional society covering the basic science underlying neuromodulation. Operates a top-tier journal (Journal of Neuroscience) and annual meeting far larger than INS's, but encompasses neuromodulation as a subset of a much broader research remit.

Market position
Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

International Neuromodulation Society

Professional Medical Society and Neuromodulation Educationneuromodulation.com

The International Neuromodulation Society is a 501(c)(3) nonprofit founded in 1989 that serves 3,000+ clinicians, scientists, and engineers across 60 countries through a peer-reviewed journal, global congresses, and 20+ regional chapters devoted to advancing neuromodulation science and education.

What International Neuromodulation Society does

The International Neuromodulation Society (INS) is a 501(c)(3) nonprofit professional society founded in 1989 and headquartered in San Francisco, California. It is the oldest and largest multidisciplinary body dedicated to neuromodulation — the alteration of nerve activity through targeted delivery of electrical stimulation or chemical agents to specific neurological sites. The INS serves clinicians, scientists, and bioengineers across neurology, neurosurgery, neurophysiology, pain management, and related disciplines, with 3,000+ members in approximately 60 countries organized through 20+ affiliated regional chapters spanning North America, South America, Europe, Asia, and Oceania. Secondary audiences include patients and caregivers, payers and policy makers, and medical journalists seeking credible information about neuromodulation therapies.

The society's core offerings center on a peer-reviewed scientific journal, recurring congresses, and digital education channels. Neuromodulation: Technology at the Neural Interface is the only MEDLINE-indexed journal dedicated exclusively to the field and has been published since 1998, currently distributed through Wiley. The annual World Congress (17th edition scheduled for Lisbon, May 9-14, 2026) and an interim meeting form the in-person scientific backbone, complemented by webinars, a Virtual Journal Club, hands-on workshops, and The Neuromodulation Podcast. Patient-facing services include condition-specific fact sheets, a searchable clinical trials database, and a Find a Clinic directory. The society is led by an Executive Director (Tia Sofatzis), a Board of Directors, and an elected President (currently Marc Russo), with a lean operating team of 1-10 staff.

The business model is a multi-stream nonprofit funding structure rather than a commercial sales motion. Revenue is generated through member dues, conference and interim meeting registration/exhibition proceeds, royalties from the Wiley-published journal, and unrestricted educational grants from neuromodulation device manufacturers including Abbott, Boston Scientific, Mainstay Medical, Medtronic, Nalu Medical, Nevro Corp., and Saluda Medical. Distribution occurs primarily through neuromodulation.com, regional chapter websites, Wiley Online Library, social media channels, and in-person congresses. The society's go-to-market motion is community-led: growth is driven by member recruitment, scientific reputation, chapter development, and the credibility of its peer-reviewed publication rather than direct sales or paid marketing.

International Neuromodulation Society firmographics

Firmographics
Name
International Neuromodulation Society
Legal name
International Neuromodulation Society
Website
https://neuromodulation.com
Company type
Private
Founded year
1989
Operating status
Operating
Headcount range
1–10 employees
Short description
The International Neuromodulation Society is a 501(c)(3) nonprofit founded in 1989 that serves 3,000+ clinicians, scientists, and engineers across 60 countries through a peer-reviewed journal, global congresses, and 20+ regional chapters devoted to advancing neuromodulation science and education.
Ownership category
akta.pro rank

Where International Neuromodulation Society is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices1 record

Markets served

International Neuromodulation Society business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Member Dues: The society collects membership dues from clinicians, scientists, and engineers who join as members.
  2. Conference Proceeds: Revenue generated from the INS World Congress and interim meetings, including registration fees and exhibition revenue.
  3. Journal Royalties: Royalties from the peer-reviewed journal Neuromodulation: Technology at the Neural Interface published by Wiley.
  4. Unrestricted Grants from Industry: The website is supported by unrestricted grants from Abbott, Boston Scientific Corporation, Mainstay Medical, Medtronic Inc., Nalu Medical, Nevro Corp., and Saluda Medical. These are charitable contributions that support website operations.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels9 records

International Neuromodulation Society product offering

Product offering

Core offering

The International Neuromodulation Society is a nonprofit professional medical society that advances the science, education, and practice of neuromodulation through a peer-reviewed journal, international congresses, webinars, podcasts, and a global network of regional chapters for clinicians, scientists, and engineers. It also delivers patient-facing educational resources including fact sheets, a clinic finder, and a clinical trials directory.

Product overview

The International Neuromodulation Society is a nonprofit professional medical society, not a technology product company. Its offerings consist of membership services and educational resources for healthcare professionals and patients. The core portfolio includes the peer-reviewed journal 'Neuromodulation: Technology at the Neural Interface' (indexed in MEDLINE since 1998), the World Congress (17th scheduled for May 2026 in Lisbon) and Interim Meetings, webinars, workshops, the Neuromodulation Podcast, and INS Regional Chapters spanning over 20 countries. Patient-facing services include fact sheets, clinical trials listings, and a clinic finder directory. The society operates member-only resources with mentorship programs and expert panels. The society does not offer commercial technology products or AI-powered solutions.

Differentiator

Problem solved

Functional benefit

Brands

  • Neuromodulation: Technology at the Neural Interface: The official peer-reviewed journal of the International Neuromodulation Society, publishing scientific works and reviews on neuromodulation.

Products and services

  • Neuromodulation: Technology at the Neural Interface (Journal) The official MEDLINE-indexed peer-reviewed journal of the INS, publishing scientific works and reviews on neuromodulation research; available to members online and via Wiley for non-members.
  • INS World Congress Flagship biennial international scientific meeting bringing together clinicians, scientists, and engineers for scientific presentations, workshops, and networking in neuromodulation.
  • INS Interim Meeting Intermediate scientific meeting held between World Congresses, providing additional education and collaboration opportunities for neuromodulation professionals.
  • INS Webinars Online educational webinars providing continuing education and the latest research updates for INS members and healthcare professionals.
  • Virtual Journal Club Online forum for discussion and analysis of recent peer-reviewed journal articles in neuromodulation.
  • INS Workshops Hands-on training workshops for medical professionals covering neuromodulation techniques and procedures.
  • The Neuromodulation Podcast Podcast series featuring discussions on emerging neuromodulation techniques, insights, ethical and clinical applications, and multidisciplinary collaboration.
  • INS Regional Chapters Network of 20+ affiliated national chapters spanning Argentina, Australia & New Zealand, Benelux, Brazil, Canada, China, Colombia, France, Germany, Italy, Japan, Korea, Nordic countries, Poland, Russia, South East Europe, Spain, Switzerland, Turkey, UK and Ireland.
  • INS Membership Services Member-only resources including journal access, mentorship programs, expert panels, educational materials, and industry news.
  • Find a Clinic Directory Directory service helping patients locate clinics offering neuromodulation treatments.
  • INS Fact Sheets Patient-focused educational fact sheets on neuromodulation therapies including deep brain stimulation, spinal cord stimulation, vagus nerve stimulation, epilepsy, and Parkinson's disease.
  • Clinical Trials Listings Searchable database of clinical trials involving neuromodulation approaches across chronic pain, movement disorders, epilepsy, psychiatric disorders, brain injury, stroke, cardiovascular, gastrointestinal, and other conditions.

Companies that use International Neuromodulation Society

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles3 records

International Neuromodulation Society technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

International Neuromodulation Society partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Wiley (Journal Publisher)coreStrategic or Co-development PartnerThe INS journal Neuromodulation: Technology at the Neural Interface is published by Wiley. The journal is indexed in Index Medicus, MEDLINE and Pubmed from its first issue in 1998 and has a growing Impact Factor.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

International Neuromodulation Society competitors and assessment

Company assessment

Regional players

  • European Academy of Neurology (EAN): Pan-European neurology professional society comparable to AAN in scope and structure, with neuromodulation as a covered subspecialty. Operates regional congresses and a peer-reviewed journal (European Journal of Neurology), serving an overlapping European clinician audience that INS reaches through its European regional chapters.

Broad incumbents

  • American Association of Neurological Surgeons (AANS): Major US neurosurgical professional society with significant neuromodulation content (DBS, SCS, etc.) and a dedicated section on pain and neuromodulation. Comparable in operating model (membership, journal Neurosurgery, annual meeting) but much broader specialty focus.
  • American Academy of Neurology (AAN): Largest US-based neurology professional society, covering neuromodulation as part of a much broader specialty. Comparable society/membership/journal/congress model but operates at vastly larger scale; many INS members also belong to AAN, making it both a competitor and a partner ecosystem.
  • World Federation of Neurosurgical Societies (WFNS): International umbrella society for national neurosurgical organizations worldwide. Overlaps with INS on the neurosurgical neuromodulation community, congress programming, and journal publication, but covers all of neurosurgery rather than specializing in neuromodulation.
  • Society for Neuroscience (SfN): Massive US-based neuroscience professional society covering the basic science underlying neuromodulation. Operates a top-tier journal (Journal of Neuroscience) and annual meeting far larger than INS's, but encompasses neuromodulation as a subset of a much broader research remit.

Direct peers

  • American Neurological Association (ANA): US-based academic neurology professional society with peer-reviewed journal (Annals of Neurology) and annual meeting. Comparable in mission and membership model to INS, with significant overlap on the academic neurology researchers who participate in neuromodulation clinical trials.
  • International Association for the Study of Pain (IASP): Global multidisciplinary professional society focused on pain research and treatment, with spinal cord stimulation and other neuromodulation modalities as a major interest area. Operates a peer-reviewed journal, congresses, and chapters — closely comparable to INS in structure, membership model, and clinical scope.
  • North American Neuromodulation Society (NANS): Direct peer and INS's North American chapter-affiliated society, also focused on neuromodulation education, research dissemination, and physician membership. Operates its own journal, annual meeting, and continuing education for neuromodulation clinicians — directly overlapping INS's core mission and audience.
  • International Parkinson and Movement Disorder Society (MDS): International scientific society for clinicians and researchers in movement disorders, including deep brain stimulation — a major neuromodulation application INS also covers. Comparable membership size, journal (Movement Disorders), and congress-driven business model, serving an overlapping physician audience.
  • International League Against Epilepsy (ILAE): International professional society for epilepsy clinicians and researchers, with vagus nerve stimulation and responsive neurostimulation as core neuromodulation topics within its scope. Operates with the same society/journal/congress model and serves an overlapping neuroscience community.

Market position

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

International Neuromodulation Society social profiles

Digital presence

International Neuromodulation Society financial estimates

Financial estimate

Revenue estimate

Valuation estimate

International Neuromodulation Society leadership team

Management profile

Number of profiles

Profiles2 records

International Neuromodulation Society funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

International Neuromodulation Society M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about International Neuromodulation Society

What does International Neuromodulation Society do?

The International Neuromodulation Society is a nonprofit professional medical society that advances the science, education, and practice of neuromodulation through a peer-reviewed journal, international congresses, webinars, podcasts, and a global network of regional chapters for clinicians, scientists, and engineers. It also delivers patient-facing educational resources including fact sheets, a clinic finder, and a clinical trials directory.

Is International Neuromodulation Society a public or private company?

International Neuromodulation Society is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was International Neuromodulation Society founded?

International Neuromodulation Society was founded in 1989. It employs 1 to 10 people.

Where is International Neuromodulation Society based?

International Neuromodulation Society is headquartered in San Francisco, United States, in the North America region.

How does International Neuromodulation Society make money?

Four revenue lines are on record. Member Dues are the primary driver. The others are conference Proceeds, journal Royalties and unrestricted Grants from Industry.

Who are International Neuromodulation Society's main competitors?

European Academy of Neurology (EAN) is listed as a regional player. Broad incumbents are American Association of Neurological Surgeons (AANS), American Academy of Neurology (AAN), World Federation of Neurosurgical Societies (WFNS) and Society for Neuroscience (SfN). Direct peers are American Neurological Association (ANA), International Association for the Study of Pain (IASP), North American Neuromodulation Society (NANS), International Parkinson and Movement Disorder Society (MDS) and International League Against Epilepsy (ILAE).

Does International Neuromodulation Society have an API?

No public API is recorded for International Neuromodulation Society.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NeuroNewsAI, cost reductions and more represent bright future for neuromodulation industryMarc Russo, president of the International Neuromodulation Society, assesses the rapid evolution of the neuromodulation industry, highlighting advancements in AI-driven devices and waveform technologies spearheaded by companies like Nevro Corporation. The article notes a strategic shift toward integrated centers of excellence and predicts that cost reductions will become the next major frontier as third-party payors recognize the therapy's cost-effectiveness. These developments are expected to improve patient outcomes and expand the adoption of brain and spinal cord stimulation therapies.PR NewswireInnovations Day Highlights Drug-free Neuromodulation TherapyThe Innovations Day session on "Disruptive Innovation: The Driving Force of Progress in Neuromodulation" will take place on May 26, 2019 at the International Convention Centre in Sydney, Australia, bringing together over 200 entrepreneurs, industry leaders, and investment professionals. The event features presentations from companies at various stages—early, intermediate, and advanced—focusing on drug-free neuromodulation therapies for chronic conditions, along with keynote talks and executive panels addressing commercialization challenges. The session precedes the International Neuromodulation Society's 14th World Congress, with the nonprofit INS serving as the organizing body.GlobeNewswireBioElectronics to Present Research at 13th World Congress of International Neuromodulation SocietyBioElectronics Corporation announced its research on pulsed shortwave therapy for increasing cardiac output in orthostatic hypotension was accepted for oral and poster presentation at the 13th World Congress of the International Neuromodulation Society in Edinburgh, May 27-31, 2017. The findings suggest ActiPatch technology could treat other chronic conditions like migraines and overactive bladder.